Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter (PREFACE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Centre Hospitalier Universitaire de Saint Etienne
Sponsor:
Collaborators:
Sanofi
Ministry of Health, France
Sorin Group
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier:
NCT00736294
First received: August 14, 2008
Last updated: January 17, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)